The Paediatric Clinical Research Infrastructure Network (PedCRIN) has launched the call for multinational clinical studies in children and neonates.
PedCRIN is a four-year project funded by the European Union’s Horizon 2020 programme, aimed to bring together the European Clinical Research Infrastructure Network (ECRIN) and the founding partners of the European Paediatric Clinical Trial Research Infrastructure (EPCT-RI) to develop capacity for the management of multinational paediatric clinical trials. PedCRIN will effectively bridge paediatricians and other partners across Europe (and internationally) to combine resources and expertise to conduct and manage robust studies, while minimising risk and protecting the child participants.
The call for application is aimed to support the multinational extension of paediatric studies on medicinal products having already secured funding in the coordinating country and to select, based on scientific excellence and evidence for feasibility, multi-national investigator-initiated paediatric or neonatal interventional clinical studies on medicinal products. The PedCRIN funding will therefore be used to support study management tasks in countries other than the coordinating country, enabling multinational patient recruitment. The eighteen (18) member countries of the PedCRIN consortium are eligible.
Here you can download the PedCRIN call for application.
The Applications should be submitted to firstname.lastname@example.org, using the PedCRIN template.
Deadline for application: 2nd May 2017 at 17.00 CET.
For more information about PedCRIN, download the project factsheet.